Sangamo Therapeutics(SGMO)

泼天财富我自来07-26 10:27

$Sangamo Therapeutics(SGMO)$ 补充更新一下
2024/7/24 该公司公布和辉瑞合作开发血友病基因药物三期达标，股价暴涨，后续可期！查看全文

产业链观察07-24 21:24

#药闻简讯# 2024 年 7 月 24 日，$辉瑞(PFE)$ 今天宣布了评估giroctocogene fitelparvovec的3期研究（NCT04370054）的积极顶线结果，该研究是一种用于治疗中度至重度血友病A成人的研究性基因疗法。$Sangamo Therapeutics(SGMO)$查看全文

当期报告

Sangamo Therapeutics(SGMO)2023-11-04 04:05

$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001628280-23-036697  Act: 34  Size: 1 MB 网页链接查看全文

员工持股计划

Sangamo Therapeutics(SGMO)2023-08-09 04:55

$Sangamo Therapeutics(SGMO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-23-206301  Act: 33  Size: 73 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)2023-08-30 04:25

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047586  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)2023-08-30 04:25

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047590  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001756  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001754  Size: 6 KB 网页链接查看全文

持股变动声明

Sangamo Therapeutics(SGMO)01-25 05:45

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-001755  Size: 6 KB 网页链接查看全文

其他

Sangamo Therapeutics(SGMO)04-20 04:25

$Sangamo Therapeutics(SGMO)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-102893  Act: 34  Size: 17 MB 网页链接查看全文

Victor_向死而生2018-05-17 08:38

$Sangamo Therapeutics, Inc.(SGMO)$ 华丽丽错过了
WALTHAM, Mass. & RICHMOND, Calif.--(BUSINESS WIRE)--Bioverativ Inc., a Sanofi company dedicated to transforming the lives of people with rare blood disorders, and Sangamo Therapeutics, Inc. (NASDAQ:SGMO) announced today ...查看全文

usbiostock2018-05-09 08:45

$Sangamo Therapeutics, Inc.(SGMO)$ 血友病A和MPS II项目数据预计在夏末公布。公司预计在2018-2019年更新7项临床研究结果。查看全文

淘沙见金2018-05-07 03:40

周末翻了翻了美国基因与细胞治疗学会( ASGCT )的摘要，感觉要比ASCO有意思的多。$Audentes Therapeutics, Inc.(BOLD)$ $Sangamo Therapeutics, Inc.(SGMO)$ $拜玛林制药(BMRN)$查看全文

股到美2018-04-11 13:37

两位阐释和证明“上帝的手术刀”-CRISPR工作原理的美女科学家杜德纳和卡朋特（居中两位）！ $药明生物(02269)$ $华大基因(SZ300676)$ $Sangamo Therapeutics, Inc.(SGMO)$查看全文

梦里逆天的喵2018-02-26 23:46

$Sangamo Therapeutics, Inc.(SGMO)$ 买四百股看看查看全文

琳子的日复一日2018-02-26 18:58

$Sangamo Therapeutics, Inc.(SGMO)$
飞起来的小象查看全文

薛定锷之猫2018-02-22 23:22

$Sangamo Therapeutics, Inc.(SGMO)$ 哭死，我10卖的查看全文

琳子的日复一日2018-02-22 21:22

$Sangamo Therapeutics, Inc.(SGMO)$
厉害了，我的SGMO！财报也超预期
Sangamo Therapeutics (NASDAQ:SGMO) inks a global collaboration agreement with Gilead Sciences (NASDAQ:GILD) unit Kite Pharma aimed at developing next-generation ex vivo (out of the body) oncolo...查看全文

琳子的日复一日2018-02-17 22:48

前几项已经陆续发布了不错的临床结果，持续关注 $Sangamo Therapeutics, Inc.(SGMO)$查看全文

空之客2018-01-31 21:47

AAV大神Prof. James Wilson在1月30日发表的论文对AAV载体的安全性提出了比较严重的质疑。
网页链接
在他的研究中，在注射较高剂量（2*10^14 gc/kg）的AAV9病毒载体后，NHP体内出现严重的毒副作用，而与病毒衣壳和外源基因引起的T细胞免...查看全文

上行空间均超50%，RBC力荐这三只潜力股

智通财经APP获悉，近期，RBC针对Verrica Pharmaceuticals(VRCA.US)、Sangamo Therapeutics(SGMO.US)、GooseHead Insurance(GSHD.US)三家公司发表研报，并强调了这三只股票未来强劲的长期增长前景，预计在未来一年的上行空间将至少达到50... 网页链接

当期报告

$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001628280-24-032815  Act: 34  Size: 287 KB 网页链接

超过5%股东持股披露「修订」

$Sangamo Therapeutics(SGMO)$ SC 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001086364-24-008122  Act: 34  Size: 12 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016686  Size: 6 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015752  Size: 8 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015753  Size: 7 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015754  Size: 7 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015755  Size: 8 KB 网页链接

当期报告

$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 5.02, 5.03, 5.07, and 9.01 Accession Number: 0001628280-24-026903  Act: 34  Size: 13 MB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014796  Size: 9 KB 网页链接

持股变动声明

$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014798  Size: 9 KB 网页链接